Liu, Stephen V. http://orcid.org/0000-0002-4852-3914
Groshen, Susan G.
Kelly, Karen
Reckamp, Karen L.
Belani, Chandra
Synold, Timothy W.
Goldkorn, Amir
Gitlitz, Barbara J.
Cristea, Mihaela C.
Gong, I-Yeh
Semrad, Thomas J.
Xu, Yucheng
Xu, Tong
Koczywas, Marianna
Gandara, David R.
Newman, Edward M.
Funding for this research was provided by:
National Cancer Institute (P30CA014089, P30CA033572, UM1 CA186717)
American Cancer Society (ACS-IRG 53-5114-0188)
Article History
Received: 26 April 2018
Accepted: 17 August 2018
First Online: 20 August 2018
Compliance with ethical standards
:
: SVL reports personal fees from Takeda, AstraZeneca, Bristol-Myers Squibb, Lilly, Taiho, and Celgene; grants from Bayer, Clovis, Corvus, Esanex, Lycera, Merck, Oncomed, Threshold, and Medimmune; and grants and personal fees from Genentech, Ignyta, and Pfizer, all outside the submitted work. BJG reports personal fees from Genentech. MK reports personal fees from AstraZeneca. DRG reports personal fees from Celgene, Guardant health, Lilly, Liquid Genomics/NANT and grants and personal fees from AstraZeneca/Medimmune and Genentech. Other authors report no relevant conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.